Leede Jones Gable provided an update on Thursday on Canadian regenerative medicine company Sernova, with analyst Douglas W. Loe commenting on a recent acquisition in the regenerative biotech space that bodes well for industry interest in companies like Sernova.
Roth Capital Partners analyst Eric Handler reviewed the latest results and coming attractions from the cinema market on Monday and reiterated a “Buy” rating on IMAX.
The current risk-reward ratio on Lightspeed Commerce is compelling, says iA Capital Markets analyst Neehal Upadhyaya in a Wednesday report on the stock.
Beacon Securities analyst Russell Stanley likes the new European acquisition by US cannabis company Curaleaf Holdings, saying in a Thursday report that it cements CURA’s position as a European leader in cannabis.
Cantech Letter hand-picks ten of the best from a range of industries, all with high yields, high market capitalization and a history of raising their dividends.
The stock has already had a tremendous 2023, but investors can expect even more upside from Kits Eyecare, according to Beacon Securities analyst Doug Cooper, who provided an update to clients on Monday.
Roth Capital Partners analyst Suji Desilva boosted his target price on D-Wave Quantum, saying D-Wave is about to ride a wave of market interest in quantum computing.